Dual Peroxisome Proliferator-Activated Receptor-α/ Agonists: In the Treatment of Type 2 Diabetes Mellitus and the Metabolic Syndrome

Author： Pershadsingh Harrihar A.  

Publisher： Adis International

ISSN： 1175-6349

Source： Treatments in Endocrinology, Vol.5, Iss.2, 2006-01, pp. : 89-99

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peroxisome Proliferator-Activated Receptor (PPAR) in Metabolic Syndrome and Type 2 Diabetes Mellitus

By  

Current Diabetes Reviews, Vol. 3, Iss. 1, 2007-02 ,pp. : 33-39

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus

By Bajaj M.   Suraamornkul S.   Hardies L.   Glass L.   Musi N.   DeFronzo R.  

Diabetologia, Vol. 50, Iss. 8, 2007-08 ,pp. : 1723-1731

Springer Publishing Company

Access to resources Recommend Favorite

Selective Peroxisome Proliferator-Activated Receptor-γ Modulation in the Treatment of Hypertension and Metabolic Syndrome: The Role of Angiotensin II Receptor Blockers

By Borghi Claudio  

High Blood Pressure & Cardiovascular Prevention, Vol. 13, Iss. 3, 2006-01 ,pp. : 81-84

Adis International

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease

By Azhar Salman  

Future Cardiology, Vol. 6, Iss. 5, 2010-09 ,pp. : 657-691

Future Medicine

Access to resources Recommend Favorite

Polymorphism in the peroxisome proliferator‐activated receptor‐ gene in women with polycystic ovary syndrome

By Korhonen S.  

Human Reproduction, Vol. 18, Iss. 3, 2003-03 ,pp. : 540-543

Oxford University Press

Access to resources Recommend Favorite